Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katja Deterding

Showing results (31-40 of 98) with videos related to

Pageof 10
Sort By:
Nature Communications|June 13, 2018
Chronic hepatitis C virus infection irreversibly impacts human natural killer cell repertoire diversityBenedikt Strunz, Julia Hengst, Katja Deterding, et al.
The Journal of Antimicrobial Chemotherapy|January 20, 2017
Successful retreatment of a patient with chronic hepatitis C genotype 2k/1b virus with ombitasvir/paritaprevir/ritonavir plus dasabuvirDaniel Todt, Bernhard Schlevogt, Katja Deterding, et al.
Journal of Clinical Microbiology|March 31, 2010
Establishment of a novel quantitative hepatitis D virus (HDV) RNA assay using the Cobas TaqMan platform to study HDV RNA kineticsIngmar Mederacke, Birgit Bremer, Benjamin Heidrich, et al.
Annals of Hepatology|October 21, 2009
Gilbert's syndrome and antiviral therapy of hepatitis CKatja Deterding, Kurt Grüngreiff, Tim O Lankisch, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 23, 2025
Value and Kinetics of Virological Markers in the Natural Course of Chronic Hepatitis D Virus InfectionLisa Sandmann, Valerie Ohlendorf, Alena Ehrenbauer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 28, 2015
Drug-Drug Interactions With Novel All Oral Interferon-Free Antiviral Agents in a Large Real-World CohortChristoph Höner Zu Siederdissen, Benjamin Maasoumy, Fiona Marra, et al.
Frontiers in Immunology|April 5, 2018
Human γδ T Cell Receptor Repertoires in Peripheral Blood Remain Stable Despite Clearance of Persistent Hepatitis C Virus Infection by Direct-Acting Antiviral Drug TherapySarina Ravens, Julia Hengst, Verena Schlapphoff, et al.
United European Gastroenterology Journal|October 6, 2018
Long-term changes in liver elasticity in hepatitis C virus-infected patients with sustained virologic response after treatment with direct-acting antiviralsVeronika Pietsch, Katja Deterding, Dina Attia, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 23, 2009
Initial presentation of acute hepatitis C virus (HCV) infection among HIV-negative and HIV-positive individuals-experience from 2 large German networks on the study of acute HCV infectionMartin Vogel, Katja Deterding, Johannes Wiegand, et al.
Journal of Viral Hepatitis|October 15, 2025
HBV Dominance Is Associated With a Distinct Inflammatory Milieu in HBV/HCV CoinfectionCarlos Oltmanns, Moana Witte, Anika Wranke, et al.
Pageof 10

Showing results (31-40 of 98) with videos related to

Sort By:
Pageof 10
Nature Communications|June 13, 2018
Chronic hepatitis C virus infection irreversibly impacts human natural killer cell repertoire diversityBenedikt Strunz, Julia Hengst, Katja Deterding, et al.
The Journal of Antimicrobial Chemotherapy|January 20, 2017
Successful retreatment of a patient with chronic hepatitis C genotype 2k/1b virus with ombitasvir/paritaprevir/ritonavir plus dasabuvirDaniel Todt, Bernhard Schlevogt, Katja Deterding, et al.
Journal of Clinical Microbiology|March 31, 2010
Establishment of a novel quantitative hepatitis D virus (HDV) RNA assay using the Cobas TaqMan platform to study HDV RNA kineticsIngmar Mederacke, Birgit Bremer, Benjamin Heidrich, et al.
Annals of Hepatology|October 21, 2009
Gilbert's syndrome and antiviral therapy of hepatitis CKatja Deterding, Kurt Grüngreiff, Tim O Lankisch, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 23, 2025
Value and Kinetics of Virological Markers in the Natural Course of Chronic Hepatitis D Virus InfectionLisa Sandmann, Valerie Ohlendorf, Alena Ehrenbauer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 28, 2015
Drug-Drug Interactions With Novel All Oral Interferon-Free Antiviral Agents in a Large Real-World CohortChristoph Höner Zu Siederdissen, Benjamin Maasoumy, Fiona Marra, et al.
Frontiers in Immunology|April 5, 2018
Human γδ T Cell Receptor Repertoires in Peripheral Blood Remain Stable Despite Clearance of Persistent Hepatitis C Virus Infection by Direct-Acting Antiviral Drug TherapySarina Ravens, Julia Hengst, Verena Schlapphoff, et al.
United European Gastroenterology Journal|October 6, 2018
Long-term changes in liver elasticity in hepatitis C virus-infected patients with sustained virologic response after treatment with direct-acting antiviralsVeronika Pietsch, Katja Deterding, Dina Attia, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 23, 2009
Initial presentation of acute hepatitis C virus (HCV) infection among HIV-negative and HIV-positive individuals-experience from 2 large German networks on the study of acute HCV infectionMartin Vogel, Katja Deterding, Johannes Wiegand, et al.
Journal of Viral Hepatitis|October 15, 2025
HBV Dominance Is Associated With a Distinct Inflammatory Milieu in HBV/HCV CoinfectionCarlos Oltmanns, Moana Witte, Anika Wranke, et al.
Pageof 10